Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Coombe

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Immunology and Cell Biology|June 1, 1997
Hepatitis B virus binding to leucocyte plasma membranes utilizes a different region of the preS1 domain to the hepatocyte receptor binding site and does not require receptors for opsoninsG J Atkins, M Qiao, D R Coombe, et al.
International Journal of Cancer|October 15, 1987
Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour-cell-derived heparanasesC R Parish, D R Coombe, K B Jakobsen, et al.
Journal of Immunological Methods|September 23, 1998
Expressed luciferase viability assay (ELVA) for the measurement of cell growth and viabilityD R Coombe, A M Nakhoul, S M Stevenson, et al.
AIDS Research and Human Retroviruses|November 1, 1995
Low anticoagulant heparin retains anti-HIV type 1 activity in vitroD R Coombe, H A Harrop, J Watton, et al.
Cellular and Molecular Life Sciences : CMLS|January 13, 2009
hShroom1 links a membrane bound protein to the actin cytoskeletonD E Dye, S Karlen, B Rohrbach, et al.
Blood|November 1, 1993
The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypesS M Watt, J Williamson, H Genevier, et al.
Biochemistry|June 7, 1994
Anti-HIV-1 activity of chemically modified heparins: correlation between binding to the V3 loop of gp120 and inhibition of cellular HIV-1 infection in vitroC C Rider, D R Coombe, H A Harrop, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Immunology and Cell Biology|June 1, 1997
Hepatitis B virus binding to leucocyte plasma membranes utilizes a different region of the preS1 domain to the hepatocyte receptor binding site and does not require receptors for opsoninsG J Atkins, M Qiao, D R Coombe, et al.
International Journal of Cancer|October 15, 1987
Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour-cell-derived heparanasesC R Parish, D R Coombe, K B Jakobsen, et al.
Journal of Immunological Methods|September 23, 1998
Expressed luciferase viability assay (ELVA) for the measurement of cell growth and viabilityD R Coombe, A M Nakhoul, S M Stevenson, et al.
AIDS Research and Human Retroviruses|November 1, 1995
Low anticoagulant heparin retains anti-HIV type 1 activity in vitroD R Coombe, H A Harrop, J Watton, et al.
Cellular and Molecular Life Sciences : CMLS|January 13, 2009
hShroom1 links a membrane bound protein to the actin cytoskeletonD E Dye, S Karlen, B Rohrbach, et al.
Blood|November 1, 1993
The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypesS M Watt, J Williamson, H Genevier, et al.
Biochemistry|June 7, 1994
Anti-HIV-1 activity of chemically modified heparins: correlation between binding to the V3 loop of gp120 and inhibition of cellular HIV-1 infection in vitroC C Rider, D R Coombe, H A Harrop, et al.
Pageof 3